₹528.75
▲ +10.72 +2.07%
As of 13 Nov 2026 · delayed
NSE Listed · Healthcare
Krsnaa Diagnostics Ltd. (KRSNAA)
Volume: 1,97,401Avg Vol 1W: 92,816Avg Vol 1M: 86,37752W Range:₹463.1₹838
Key Ratios
Checked just nowMarket Cap₹1,715 Cr
Current Price₹528.75
Previous Close₹518.03
High / Low (52w)₹838 / ₹463.1
Volume1,97,401
Avg Vol (1W)92,816
Avg Vol (1M)86,377
Stock P/E17.49
Book Value₹320.19
Dividend Yield38%
ROE9.45%
ROA475.44%
Revenue (TTM)—
Revenue Growth15.74%
Profit Margin11.15%
Total Debt₹19 Cr
Shares Outstanding3 Cr
Face Value₹5
EPS (TTM)₹30.24
P/B1.65
Debt / Equity0.4
50 DMA₹530.62
200 DMA₹571.58
Day change+2.07%
Price Chart
₹528.75▼ 34.41% · 1Y
2025-11-142026-11-13
20-day avg volume: 91K shares
Pros
- Pays a dividend yield of 38.0%.
- Company is almost debt-free.
- Revenue grew 14% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹175 Cr | ₹186 Cr | ₹193 Cr | ₹206 Cr | ₹181 Cr | ₹193 Cr | ₹236 Cr | ₹271 Cr |
| EBITDA | ₹32 Cr | ₹35 Cr | ₹34 Cr | ₹40 Cr | ₹28 Cr | ₹64 Cr | ₹37 Cr | ₹48 Cr |
| Net Profit | ₹19 Cr | ₹21 Cr | ₹21 Cr | ₹24 Cr | ₹15 Cr | ₹42 Cr | ₹17 Cr | ₹25 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹743 Cr | ₹176 Cr | ₹183 Cr | ₹159 Cr | ₹816 Cr | ₹173 Cr | ₹211 Cr | ₹240 Cr |
| EBITDA | ₹127 Cr | ₹33 Cr | ₹39 Cr | ₹29 Cr | ₹165 Cr | ₹66 Cr | ₹36 Cr | ₹49 Cr |
| Net Profit | ₹78 Cr | ₹20 Cr | ₹23 Cr | ₹16 Cr | ₹101 Cr | ₹43 Cr | ₹16 Cr | ₹25 Cr |
| EPS | 23.56 | — | — | — | 30.88 | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹630 Cr | ₹609 Cr | ₹876 Cr | ₹910 Cr | ₹1,172 Cr | ₹1,282 Cr | ₹1,824 Cr |
| Total Liabilities | ₹827 Cr | ₹377 Cr | ₹192 Cr | ₹171 Cr | ₹362 Cr | ₹399 Cr | ₹843 Cr |
| Equity | ₹-197 Cr | ₹232 Cr | ₹684 Cr | ₹739 Cr | ₹810 Cr | ₹883 Cr | ₹980 Cr |
| Total Debt | ₹123 Cr | ₹153 Cr | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹126 Cr | ₹135 Cr | ₹89 Cr | ₹43 Cr | ₹107 Cr | ₹171 Cr |
| Investing | ₹-67 Cr | ₹-241 Cr | ₹-109 Cr | ₹-129 Cr | ₹-100 Cr | ₹-396 Cr |
| Financing | ₹20 Cr | ₹176 Cr | ₹-33 Cr | ₹84 Cr | ₹14 Cr | ₹279 Cr |
| Free Cash Flow | ₹126 Cr | ₹135 Cr | ₹89 Cr | ₹43 Cr | ₹107 Cr | ₹171 Cr |
Shareholding
Promoter 27.11% Institutions 18.34% Public 54.54%
Efficiency & Working Capital
ROCE10.3%
Interest Coverage4.8
Dividend Payout—
Debtor Days140 d
Inventory Days13 d
Payable Days30 d
Cash Conversion Cycle122 d
Working Capital Days152 d
Shareholding Details
As of 2026-09-30
Promoter27.1%
FII3.8%
DII14.5%
Institutions18.3%
Public54.5%
Promoter Pledge0%
No. of Shareholders50,671
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27% | 27% | 27.2% | 27.2% | 27.2% | 27.2% | 27.1% | 27.1% | 27.1% | 27.1% | 27.1% | 27.1% |
| FIIs | 3.4% | 3.3% | 3.3% | 3.6% | 4% | 3.6% | 3.4% | 3.7% | 4.2% | 3.9% | 4.3% | 3.8% |
| DIIs | 16.3% | 15.4% | 15.3% | 15.9% | 14.5% | 14.3% | 14.2% | 15% | 13.9% | 13.9% | 14.5% | 14.5% |
| Public | 53.2% | 54.3% | 54.2% | 53.3% | 54.3% | 54.9% | 55.2% | 54.3% | 54.9% | 55.1% | 54.1% | 54.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 57,232 | 56,458 | 55,914 | 53,519 | 52,799 | 53,559 | 54,262 | 52,117 | 52,380 | 53,022 | 53,625 | 50,671 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajendra Khivraj Mutha | Shareholding of Promoter and Promoter Group | 24.8% | 80,29,920 |
| Phi Capital Trust - Phi Capital Growth Fund - I | Public Shareholding | 15.4% | 49,84,967 |
| Tata Mutual Fund - Tata Small Cap Fund | Public Shareholding | 8% | 26,08,076 |
| Krsna Diagnostics (mumbai) Private Limited | Shareholding of Promoter and Promoter Group | 2.4% | 7,65,685 |
| Amicorp Capital (mauritius) Limited | Public Shareholding | 2.2% | 7,06,035 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 2% | 6,62,512 |
| Bandhan Small Cap Fund | Public Shareholding | 2% | 6,41,206 |
| Medimaze Solutions Private Limited | Public Shareholding | 1% | 3,33,184 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Rajendra Mutha | Chairman / Executive Director / WTD | 2025 |
| Yash Mutha | Executive Director & MD | 2025 |
| Prem Pradeep | Non Executive Director / Nominee | 2025 |
| Chetan Desai | Independent Non Exe. Director | 2025 |
| Adesh Gupta | Independent Non Exe. Director | 2025 |
| Mr. Sujoy Sudipta Bose | Company Sec. & Compli. Officer | 2025 |
| Raju Venkatraman | Additional Director | 2025 |
| Jessie Paul | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| providing Radiology and Pathology s | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹5 | 147 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-09-18 | ₹2 (40%) | Final |
| forthcoming | 2026-09-18 | Dividend | — |
| forthcoming | 2026-08-13 | Board Meetings | — |
| dividend | 2025-09-12 | ₹2.75 (55%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 59 | 0 | 0 | 7 | 0 | 70 |
| 2026 | 0 | 0 | 0 | 7 | 0 | 11 |
| 2026 | 59 | 0 | 0 | 0 | 0 | 59 |
Insider / Designated-Person Trades
13 recent disclosure(s)
Krsna Diagnostics Mumbai Private LimitedAcquisition · 22,929
KRSNA DIAGNOSTICS MUMBAI PRIVATE LIMITEDAcquisition · 45,000
Krsna Diagnostics Mumbai Private LimitedAcquisition · 1,30,000
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 7,700
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 10,000
Phi Capital Trust û Phi Capital Growth Fund û 1Acquisition · 10,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Pref. Allotment13/10/2026 · —
Company Information
🌐 www.krsnaadiagnostics.com ↗
📍 S.No. 243/A Hissa No.6 Near, Chinchwad Station Chinchwad, Pune, Maharashtra, 411019
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search